Giuliano Perotti Bernardini

Has grant

University Medical Center Groningen
Country flagNetherlands

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Real-time Adaptive Particle Therapy of Cancer

Open Date: 2021-03-01

Close Date: 2025-08-31

Articles (6)

Year:

2026

Objectives. Breast cancer patients treated with proton therapy receive weekly repeat CTs (rCT) for treatment evaluation. However, plan adaptations are rarely necessary in our department. Therefore, the goal of this study was to develop an online method using surface guided radiotherapy (SGRT) to predict the dosimetric impact of changes in breast anatomy to identify patients that require plan adaptations, in order to reduce the number of rCTs. Approach. Seven breast cancer patients, treated with proton therapy with daily 3D surface-images in treatment position used for SGRT, were included. Clinical proton and backup photon plans were available. A novel in-house developed method, Dose Impact Prediction from Surface Imaging (DIPSI), was used to quantify the deformation between the planning CT (pCT) BODY contour, and the daily 3D SGRT surface images. To validate DIPSI, known isotropic deformations of 2, 4, 6, 8, 10 and 15 mm were introduced in the pCT BODY contour surrounding the clinical target volume (CTV). Clinical proton and photon treatment plans were recalculated including this deformation to evaluate the dosimetric impact of known deformations on the CTV D98%, D2% and average dose (Dmean). Deformation thresholds were determined to detect unacceptable dose deviations, from which the corresponding sensitivity, specificity and false negative rate were determined. Main results. DIPSI showed an accuracy of 0.2 mm and perfect correlation with known deformations ( R 2 = 1.00). Optimal thresholds to trigger treatment plan adaptation were 6.0 mm for the proton plan and 10.0 mm for the photon plan, resulting in sensitivities >95.5%, specificities >93.9% and false negative rates <1.6% in identifying breast deformations that require plan adaptations. Significance. Breast surface deformations could accurately be determined from daily SGRT images, making them suitable in identifying patients that require plan adaptations in photon and proton therapy potentially reducing the need for rCTs.

Year:

2025

Year:

2025

Background In online adaptive proton therapy (OAPT), additional treatment verification techniques are crucial for detecting treatment deviations and acting as a safety net, as phantom‐based patient‐specific quality assurance methods are not applicable. Prompt gamma imaging (PGI) has the potential for online treatment verification without adding dose nor prolonging treatment. PGI has proven to detect relevant anatomical changes under real‐world clinical conditions. Range probing (RP) has shown its clinical applicability for in‐vivo proton range assessment before treatment, thereby helping to address uncertainties. It has been proven useful for quality control of cone‐beam CT‐based synthetic CTs, suggesting its adoption into OAPT. Purpose The performance of PGI and RP, two different yet complementary treatment verification methods, was compared by consecutive measurements within one experimental setup. Anatomical changes (AC) and setup errors (SE) were mimicked in an anthropomorphic head phantom. Methods The PGI‐system was positioned beneath the phantom while the RP‐system was positioned distally, allowing a simultaneous setup of both systems at a horizontal gantry angle. A brain target was irradiated with a 1‐field pencil‐beam scanning treatment plan and a low‐dose RP‐plan with high‐energy protons that passed through the phantom. Upstream and downstream positioned water‐equivalent material slabs of 2/3/5 mm or 5 mm thicknesses mimicked AC within the beam path or beyond the target, respectively. Additionally, the couch was shifted 2 and 3 mm in left, down and upstream direction in beam's eye view (BEV), mimicking SE. Both plans were delivered and monitored 10 times for each AC and SE configuration. Geometrical range shifts measured with PGI were converted to water‐equivalent thickness range shifts for direct comparison between PGI and RP results. Results Both systems detected range deviations relevant for the treatment field, caused by AC within the clinical beam path. RP measurements were more precise for all scenarios (RP: 1σ ≤ 0.3 mm, PGI: 1σ ≤ 0.8 mm). PGI was similarly accurate for the 2 mm slab while slightly underestimating 3 and 5 mm slabs (≤ 0.7 mm). Only RP detected AC beyond the target, which are irrelevant for the monitored treatment field. Both systems detected expected range shifts of all SEs. RP was more accurate than PGI (RP: within 0.3 mm, PGI: within 0.8 mm). The couch movement left in BEV was detected with slightly higher precision using PGI (RP: 1σ ≤ 1.0 mm, PGI: 1σ ≤ 0.9 mm), while the precision of detecting the couch movement down in BEV was the same for both systems (1σ ≤ 0.7 mm). Only PGI recognized couch movements upstream (accuracy within 0.4 mm). Conclusion Both PGI and RP precisely detected introduced AC relevant for the monitored treatment field. SE were detected, but with greater uncertainty. While the current implementation of RP enables pretreatment range verification after setup imaging with a low‐dose RP‐field, PGI enables treatment verification during field delivery, detecting range deviations relevant for the treatment field. The simultaneous setup of PGI and RP clearly demonstrated their compatibility in a clinical setting, the unique advantages of each system and their crucial role as safety nets in OAPT.

Year:

2025

Year:

2025

Background Intensity‐modulated proton therapy (IMPT) holds promise for improving outcomes in head‐and‐neck cancer (HNC) patients by enhancing organ‐at‐risk (OAR) sparing. A key challenge in IMPT is ensuring an accurate dose delivery at the distal edge of the tumor, where the steep dose gradients make treatment precision highly sensitive to uncertainties in both proton range and patient setup. Thus, IMPT conformality is increased by incorporating robust margins in the treatment optimization. However, an increment in the plan robustness could lead to an OAR overdosing. Therefore, an accurate distal edge verification during dose delivery is crucial to increase IMPT conformality by reducing optimization settings in treatment planning. Purpose This work aims to evaluate, in a quasi‐clinical setting, a novel approach for accurate instantaneous proton beam distal edge verification in IMPT by means of spot‐by‐spot positron emission tomography (PET) imaging. Methods An anthropomorphic head and neck phantom CIRS‐731 HN was irradiated at the head and neck region. The targets were defined as 4 cm diameter spheres. A 60‐ms delay was introduced between the proton beam spots in order to enable the spot‐by‐spot coincidence detection of the 511‐keV photons resulting from positron annihilation following the positron emission from very short‐lived positron‐emitting, mainly 12 N ( T 1/2 = 11.0 ms). Additionally, modified irradiations were carried out using solid water slabs of 2 and 5 mm thickness in the beam path to assess the precision of the approach for detecting range deviations. The positron activity range (PAR) was determined from the 50% distal fall‐off position of the 1D longitudinal positron activity profile derived from the 2D image reconstructions. Furthermore, Monte Carlo (MC) simulations were performed using an in‐house RayStation/GATE MC framework to predict the positron activity images and verify the PAR measurements. Results PAR measurements achieved a precision between 1.5 and 3.6 mm (at 1.5σ clinical level) at the beam spot level within sub‐second time scales. Measured PAR shifts of 1.6–2.1 and 4.2‐–.7 mm were observed with the 2‐ and 5‐mm thickness range shifters, respectively, aligning with the corresponding proton dose range (PDR) shifts of 1.3–1.8 and 3.9–4.3 mm. The simulated PAR agrees with the measured PARs, showing an average range difference of ∼0.4 mm. Conclusion This study demonstrated the feasibility of instantaneous distal edge verification using PET imaging by introducing beam spot delays during dose delivery. The findings represent a first step toward the clinical implementation of instantaneous in vivo distal edge verification. The approach contributes to the development of real‐time range verification aimed at improving IMPT treatments by mitigating range and setup uncertainties, thereby reducing dose to organs‐at‐risk and ultimately enhancing patient outcomes.

Year:

2025

Collaborators (5)

Stine Sofia Korreman

Professor

Aarhus University

DENMARK
View details

Nanna Maria Sijtsema

University Medical Center Groningen

NETHERLANDS
View details

John H. Maduro

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Peter van Ooijen

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Christian Richter

Head of Medical Radiation Physics Section

Helmholtz-Zentrum Dresden-Rossendorf

GERMANY
View details